Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,289 recruiting studies in this area right now.
By phase
- Not applicable9,592
- Phase 24,427
- Phase 12,674
- Phase 1/Phase 21,648
- Phase 31,398
- Phase 2/Phase 3284
- Phase 4266
Top conditions
- Breast Cancer1,208
- Prostate Cancer646
- Cancer638
- Colorectal Cancer481
- Lung Cancer422
- Ovarian Cancer342
- Multiple Myeloma330
- Pancreatic Cancer289
- Gastric Cancer285
- Acute Myeloid Leukemia279
- Hepatocellular Carcinoma256
- Solid Tumor245
- Advanced Solid Tumor232
- Head and Neck Cancer228
- Cervical Cancer225
- Endometrial Cancer214
- Advanced Solid Tumors206
- Esophageal Cancer190
Leading sponsors
- M.D. Anderson Cancer Center453
- Fudan University305
- National Cancer Institute (NCI)294
- Memorial Sloan Kettering Cancer Center291
- Sun Yat-sen University275
- Mayo Clinic238
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences145
- City of Hope Medical Center145
- AstraZeneca133
- Ruijin Hospital128
Where studies are running
- California1,406
- Texas629
- Arizona508
- Florida434
- Alabama428
- New York406
- Massachusetts339
- Maryland331
- New Jersey275
- Pennsylvania235
Recruiting studies20,289 total
- NCT05844514Recruiting
Breath test study for colorectal cancer detection and risk
This study tests a breath analysis (a sample you give by breathing into a device) to help detect or better understand colorectal cancer. It may help researchers see whether breath results can identify cancer sooner and in people who haven’t started treatment yet.
LondonAges 18 years+ - NCT06326957Recruiting
Online program for chronic breathlessness
This trial tests an internet-based self-guided program to help adults with chronic breathlessness. It is designed for people who still feel short of breath despite treatment for conditions like COPD, lung disease, or cancer.
LondonAges 18–110 - NCT06186726RecruitingPhase 2
Carbon ion radiation with chemo for thymic cancer
This trial tests a new type of radiation (carbon ion) plus chemotherapy for thymic tumors that cannot be removed with surgery. It aims to see if this combination can effectively treat the cancer while protecting healthy organs.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06311981RecruitingPhase 2
Carbon ion radiation for elderly lung cancer patients
This trial tests carbon ion radiotherapy for adults 75 and older with locally advanced non-small cell lung cancer who cannot have surgery. The goal is to see if this precise type of radiation can treat the cancer effectively with fewer side effects.
Shanghai, Shanghai MunicipalityAges 75 years+ - NCT06648733Recruiting
Better medication safety when leaving the hospital for palliative care
This trial studies how to improve medication management when patients with advanced illnesses move from hospital care to home care in Muenster. It aims to make the switch smoother and safer for people who need palliative (comfort-focused) treatment.
Münster, North Rhine-WestphaliaAges 18 years+ - NCT06684652Recruiting
Comparing targeted plus standard biopsies for prostate cancer diagnosis
This trial tests whether adding a targeted biopsy to a standard sextant biopsy improves the detection of prostate cancer. It is for men aged 45 to 85 who have a suspicious spot on an MRI of their prostate and have not had a biopsy before.
Beijing, Beijing MunicipalityAges 45–85 - NCT06947083RecruitingPhase 2
Elranatamab after cilta-cel for high-risk multiple myeloma
This trial tests a new drug, elranatamab, for people with multiple myeloma who recently received a CAR-T cell therapy (cilta-cel) but still have high-risk features. The goal is to see if elranatamab can help keep the cancer from coming back.
Tampa, FloridaAges 18 years+ - NCT06947668Recruiting
Biomarker study for people who can't take cisplatin chemo
This study looks at immune system markers in patients with head and neck cancer who cannot receive the standard chemotherapy drug cisplatin. The goal is to understand how well a different chemotherapy drug (docetaxel) combined with radiation works in these patients.
Erlangen, BavariaAges 18 years+ - NCT06951997RecruitingPhase 2
First treatment for metastatic pancreatic cancer using three drugs
This trial tests a new combination of three drugs (QL1706, chidamide, and AG) as the very first treatment for people with metastatic pancreatic cancer. The goal is to see if this combination is safe and effective, and it may offer a new option for those who have not had any prior therapy.
TianjinAges 18–75 - NCT06943313Enrolling by invitation
Breast cancer PET/CT imaging with a new tracer
This trial tests a new imaging agent (68Ga-pAKTi) that may help doctors see breast cancer cells with a PET/CT scan. It is for people with a specific genetic change in their tumor, and who have not yet had surgery to remove the cancer.
ShanghaiAges 18 years+ - NCT06943807Recruiting
Stomach cancer screening using a stool DNA test
This study tests a new way to screen for stomach cancer by looking for special DNA markers in your stool. It might help find cancer early without needing an endoscopy right away.
TonglingAges 40 years+ - NCT06946654Recruiting
Health Check for Older Adults Before Stem Cell Transplant
This study looks at whether a special health evaluation designed for older adults can help doctors better plan stem cell transplants for people 55 and older with blood disorders. You would receive a series of questionnaires and tests to assess your overall health before transplant.
BeijingAges 55 years+ - NCT06943547Enrolling by invitation
Study to improve cervical cancer screening in Puerto Rico
This trial tests how well certain programs can increase cervical cancer screening among women in Puerto Rico. If you are overdue for a Pap or HPV test, this study may help you get screened.
San Juan, PRAges 25–65 - NCT06949098RecruitingPhase 2
Local tumor removal plus chemo-radiation for early low rectal cancer
This trial tests whether removing just the tumor locally, followed by chemotherapy and radiation, is effective for early-stage (T1-2 N0) rectal cancers located low or very low in the rectum. It may help you keep your anal opening and avoid major surgery that requires a permanent colostomy bag.
Shijiazhuang, HebeiAges 18–75 - NCT06946238Recruiting
Single-dose radiation after surgery for low-risk breast cancer
This trial tests giving a single, very targeted dose of radiation right after surgery for early-stage breast cancer. It is for women age 40+ with small, low-risk tumors (Luminal A or B) that have been fully removed and have not spread to lymph nodes.
MilanAges 40 years+ - NCT06945042Recruiting
Financial help for adults with new AML starting chemo
This study is testing whether a financial navigation program can help adults with newly diagnosed acute myeloid leukemia (AML) who are about to start or have just started intensive chemo. The goal is to see if providing money guidance reduces stress and improves their care.
Charlotte, North CarolinaAges 18–64 - NCT06949033RecruitingPhase 3
Cadonilimab with chemo for stomach cancer
This trial tests a new combination of immunotherapy (cadonilimab) and chemotherapy before and after surgery for a specific type of advanced stomach or gastroesophageal junction cancer. It aims to see if adding this immunotherapy helps shrink tumors and improve outcomes.
Lanzhou, GansuAges 18–75 - NCT06945887Recruiting
Arterial embolization for desmoid tumors
This trial tests a treatment called arterial embolization for desmoid tumors (non-cancerous growths) that are causing symptoms and growing. The goal is to see if blocking the blood supply to the tumor can shrink it or stop it from growing.
Bologna, BOAges 12 years+ - NCT06952101Recruiting
Personalized treatment for rectal cancer to save the organ
This trial tests a personalized, step-by-step approach for rectal cancer that aims to avoid surgery and preserve the rectum. It is for patients whose tumor has shrunk significantly after chemoradiation, or who have early-stage high-risk cancer removed during a scope procedure.
Candiolo, TurinAges 18 years+ - NCT06951646RecruitingPhase 2
Personalized treatment for advanced lung cancer with long response to first-line therapy
This trial tests a combination of ivonescimab and docetaxel for people with advanced non-small cell lung cancer who have had a long response (11-15 months without the cancer getting worse) to first-line immunotherapy. The goal is to see if adjusting treatment based on ctDNA-MRD levels can improve outcomes.
ChangshaAges 18–75 - NCT06948552RecruitingPhase 2
Using a light-sensitizing drug to find cancer in the upper urinary tract
This trial tests whether taking a drug called 5-ALA before a scope procedure helps doctors spot cancer cells in the upper urinary tract more clearly. If you are having a scope to check for or treat a tumor in this area, this experimental imaging method might help guide treatment.
Detroit, MichiganAges 18–75 - NCT06943612Recruiting
Studying colon surgery in retroperitoneal sarcoma patients
This study looks at people with rare abdominal sarcomas who also had part of their colon removed during surgery. It aims to understand how these combined surgeries affect outcomes, helping doctors better care for future patients.
Mannheim, Baden-WurttembergAges 18 years+ - NCT06951659Recruiting
Balance and vision study after brain tumor surgery
This study looks at how brain tumors and their surgery can affect your sense of balance and vision. You will be asked to do some simple tests to help researchers understand these changes.
Perth, Western AustraliaAges 18–80 - NCT06946602Recruiting
Study of transplant preparation for older adults with AML
This trial tests a special preparation (conditioning) regimen for patients 55 or older with acute myeloid leukemia (AML) who are in first remission and receiving a half-matched (haploidentical) stem cell transplant. It aims to make the transplant safer and more effective for this age group.
BeijingAges 55 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,289 recruiting oncology studies from the U.S. registry right now, out of 31,083 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.